Results 211 to 220 of about 26,054,471 (361)

Breaking New Ground: An Evaluation of Susceptibility Breakpoints for Echinocandins against Candida Species [PDF]

open access: gold, 2017
Justin Bader   +4 more
openalex   +1 more source

Moyamoya Disease and the Risk of Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo   +9 more
wiley   +1 more source

<i>Metapetrocosmeanavicularis</i>, a new species of Gesneriaceae in Vietnam. [PDF]

open access: yesPhytoKeys
Li QY   +6 more
europepmc   +1 more source

Scalesia gordilloi a new Galapagos plant species [PDF]

open access: yes, 1986
Hamann, Ole, Wium-Andersen, Søren
core  

Seven new species of Oculatella (Pseudanabaenales, Cyanobacteria): taxonomically recognizing cryptic diversification

open access: yes, 2014
Karina Osorio-Santos   +6 more
semanticscholar   +1 more source

Global rise in emerging alien species results from increased accessibility of new source pools

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2018
H. Seebens   +49 more
semanticscholar   +1 more source

Exosome Proteomics of SOD1D90A Mutation Suggest Early Disease Mechanisms, and FN1 as a Biomarker

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease. Super oxide dismutase 1 (SOD1) gene mutations cause ALS, and the D90A mutation is associated with primarily upper motor neuron (UMN) loss. Objective Our goal is to reveal the early cellular events in ALS pathology and identify potential pharmacokinetic biomarkers, using well ...
Mukesh Gautam   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy